Sign in

CIK 0001737953 · Non-accelerated filer<br>Smaller reporting company

Replimune Group, Inc.

Sign in to watch
Ticker
REPL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
operating
EIN
822082553
Phone
(781) 222-9600
Business address
500 UNICORN PARK, WOBURN, MA, 01801
  1. 4 Open-market sale Director sold 5,200 shares at $21.80 ($113,360)
  2. SCHEDULE 13G Stake Statement of Beneficial Ownership
  3. 144 Insider Sale of Securities
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. 10-Q/A Report 10-Q/A
  6. 4 Insider Changes in Ownership
  7. 144 Insider Sale of Securities
  8. 144 Insider Sale of Securities
  9. 144 Insider Sale of Securities
  10. 144 Insider Sale of Securities
  11. 10-Q Report Quarterly Report
  12. 8-K Event Results of operations
  13. 8-K Event Bylaws or fiscal year change · Shareholder vote results
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. S-3ASR Offering Registration Statement
  17. 10-Q Report Quarterly Report
  18. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  19. 8-K Event Results of operations
  20. 4 Insider Changes in Ownership

Page 1 of 34 · 662 filings